{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:37:09Z","timestamp":1781609829612,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005133","name":"Hormel Foundation","doi-asserted-by":"publisher","award":["HHSN261200421"],"award-info":[{"award-number":["HHSN261200421"]}],"id":[{"id":"10.13039\/100005133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005133","name":"Hormel Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005133","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["N01CN35000"],"award-info":[{"award-number":["N01CN35000"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ebiom.2019.10.038","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:51:12Z","timestamp":1573087872000},"page":"145-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Targeting the COX1\/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development"],"prefix":"10.1016","volume":"49","author":[{"given":"Tianshun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Ya","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruihua","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan R.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Limburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad G.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-4028","authenticated-orcid":false,"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9864","key":"10.1016\/j.ebiom.2019.10.038_bib0001","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(12)60643-6","article-title":"Oesophageal carcinoma","volume":"381","author":"Pennathur","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ebiom.2019.10.038_bib0002","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1111\/j.1572-0241.2008.02191.x","article-title":"Continuing rapid increase in esophageal adenocarcinoma in England and Wales","volume":"103","author":"Lepage","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrc2773","article-title":"Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis","volume":"10","author":"Reid","year":"2010","journal-title":"Nature Rev Cancer"},{"issue":"6","key":"10.1016\/j.ebiom.2019.10.038_bib0004","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ajg.2013.72","article-title":"Age at onset of Gerd symptoms predicts risk of Barrett's esophagus","volume":"108","author":"Thrift","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"9666","key":"10.1016\/j.ebiom.2019.10.038_bib0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(09)60487-6","article-title":"Barrett's oesophagus","volume":"373","author":"Shaheen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2019.10.038_bib0006","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-91830-3_3","article-title":"Esophageal adenocarcinoma: pathogenesis and epidemiology","author":"Schlottmann","year":"2018","journal-title":"Esophageal Cancer: Springer"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0007","first-page":"G47","article-title":"Altered sodium-hydrogen exchange activity is a mechanism for acid-induced hyperproliferation in Barrett's esophagus","volume":"275","author":"Fitzgerald","year":"1998","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.10.038_bib0008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0016-5085(00)70254-X","article-title":"Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure","volume":"118","author":"Shirvani","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","article-title":"CYCLOOXYGENASES 1 and 2","volume":"38","author":"Vane","year":"1998","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.10.038_bib0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nrc2809","article-title":"Eicosanoids and cancer","volume":"10","author":"Wang","year":"2010","journal-title":"Nature Rev Cancer"},{"issue":"3\u20134","key":"10.1016\/j.ebiom.2019.10.038_bib0011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s10555-007-9096-5","article-title":"Cyclooxygenases, prostanoids, and tumor progression","volume":"26","author":"Wang","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ebiom.2019.10.038_bib0012","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-09-0788","article-title":"Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward","author":"Menter","year":"2010","journal-title":"Clinical Cancer Res"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/gut.53.1.27","article-title":"Expression of cyclooxygenase 2, microsomal prostaglandin e synthase 1, and EP receptors is increased in rat oesophageal squamous cell dysplasia and Barrett's metaplasia induced by duodenal contents reflux","volume":"53","author":"Jang","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0014","first-page":"G327","article-title":"Acid-and bile-induced PGE2 release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-\u03b5 dependent","volume":"283","author":"Kaur","year":"2002","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.ebiom.2019.10.038_bib0015","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/j.gastro.2012.06.044","article-title":"A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus","volume":"143","author":"Falk","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ebiom.2014.12.004","article-title":"Circulating prostaglandin biosynthesis in colorectal cancer and potential clinical significance","volume":"2","author":"Li","year":"2015","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0017","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/onc.2010.390","article-title":"4-Methylnitrosamino-1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane a 2 and its receptor","volume":"30","author":"Huang","year":"2011","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0018","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41698-017-0011-4","article-title":"Inhibiting breast cancer by targeting the thromboxane a 2 pathway","volume":"1","author":"Li","year":"2017","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0019","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1053\/gast.2003.50008","article-title":"Protective association of aspirin\/NSAIDs and esophageal cancer: a systematic review and meta-analysis","volume":"124","author":"Corley","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.ebiom.2019.10.038_bib0020","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.cgh.2012.02.031","article-title":"Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis","volume":"10","author":"Omer","year":"2012","journal-title":"Clinical Gastroenterol Hepatol"},{"key":"10.1016\/j.ebiom.2019.10.038_bib0021","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-313584","article-title":"Aspirin prevents nf-\u03bab activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus","author":"Huo","year":"2017","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056884","article-title":"Warburg and Crabtree effects in premalignant Barrett's esophagus cell lines with active mitochondria","volume":"8","author":"Suchorolski","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2019.10.038_bib0023","doi-asserted-by":"crossref","unstructured":"He J., Fang Y., Chen X. Surgical models of gastroesophageal reflux with mice. JoVE (Journal of Visualized Experiments). 2015(102):e53012.","DOI":"10.3791\/53012"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0024","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"4","key":"10.1016\/j.ebiom.2019.10.038_bib0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/path.1711620403","article-title":"Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some, neoplasms","volume":"162","author":"Hall","year":"1990","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.ebiom.2019.10.038_bib0026","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/cncr.27834","article-title":"Trends in esophageal adenocarcinoma incidence and mortality","volume":"119","author":"Hur","year":"2013","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.ebiom.2019.10.038_bib0027","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"New Engl J Med"},{"issue":"15","key":"10.1016\/j.ebiom.2019.10.038_bib0028","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett's esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"New Engl J Med"},{"issue":"10184","key":"10.1016\/j.ebiom.2019.10.038_bib0029","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0030","first-page":"527","article-title":"Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice","volume":"40","author":"Santander","year":"2012","journal-title":"Int J Oncol"},{"issue":"9b","key":"10.1016\/j.ebiom.2019.10.038_bib0031","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1111\/j.1582-4934.2008.00430.x","article-title":"Cyclooxygenase in normal human tissues\u2013is COX\u20101 really a constitutive isoform, and COX2 an inducible isoform?","volume":"13","author":"Zidar","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"22","key":"10.1016\/j.ebiom.2019.10.038_bib0032","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ebiom.2019.10.038_bib0033","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J Receptors Signal Transduction"},{"issue":"15","key":"10.1016\/j.ebiom.2019.10.038_bib0034","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1093\/emboj\/17.15.4426","article-title":"Mitogen and stress activated protein kinase\u20101 (MSK1) is directly activated by MAPK and SAPK2\/p38, and may mediate activation of CREB","volume":"17","author":"Deak","year":"1998","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.ebiom.2019.10.038_bib0035","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.cellsig.2006.05.004","article-title":"ERK1\/2 and p38-MAPK signalling pathways, through MSK1, are involved in NF-\u03baB transactivation during oxidative stress in skeletal myoblasts","volume":"18","author":"Kefaloyianni","year":"2006","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.ebiom.2019.10.038_bib0036","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/MCB.22.8.2871-2881.2002","article-title":"MSK1 and MSK2 are required for the mitogen-and stress-induced phosphorylation of CREB and ATF1 in fibroblasts","volume":"22","author":"Wiggin","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.ebiom.2019.10.038_bib0037","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ccr.2007.03.009","article-title":"Rewired ERK-JNK signaling pathways in melanoma","volume":"11","author":"Lopez-Bergami","year":"2007","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0038","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/nyas.12252","article-title":"Barrett's esophagus: cancer and molecular biology","volume":"1300","author":"Gibson","year":"2013","journal-title":"Ann N Y Acad. Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0039","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-\u03baB a good target for cancer therapy? Hopes and pitfalls","volume":"8","author":"Baud","year":"2009","journal-title":"Nature Rev Drug Discov"},{"issue":"11","key":"10.1016\/j.ebiom.2019.10.038_bib0040","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.3748\/wjg.v21.i11.3174","article-title":"Nuclear factor kappa B role in inflammation associated gastrointestinal malignancies","volume":"21","author":"Gambhir","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ebiom.2019.10.038_bib0041","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1053\/j.gastro.2011.11.019","article-title":"Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis","volume":"142","author":"Liao","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.ebiom.2019.10.038_bib0042","first-page":"e131","article-title":"Aspirin use is associated with lower risk of Barrett's esophagus in women","volume":"8","author":"Jovani","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"9759","key":"10.1016\/j.ebiom.2019.10.038_bib0043","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0044","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/annonc\/mdu225","article-title":"Estimates of benefits and harms of prophylactic use of aspirin in the general population","volume":"26","author":"Cuzick","year":"2014","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ebiom.2019.10.038_bib0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","article-title":"Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention","volume":"36","author":"Zacharias-Millward","year":"2017","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.1016\/j.ebiom.2019.10.038_bib0046","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/MCG.0000000000001027","article-title":"Barrett esophagus length, nodularity, and low-grade dysplasia are predictive of progression to esophageal adenocarcinoma","volume":"53","author":"Solanky","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.ebiom.2019.10.038_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169691","article-title":"Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett's esophagus: a systematic review and meta-analysis","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ebiom.2019.10.038_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)31388-6","article-title":"Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial","author":"Jankowski","year":"2018","journal-title":"Lancet"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419307091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419307091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:56:57Z","timestamp":1762455417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419307091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":48,"alternative-id":["S2352396419307091"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.038","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the COX1\/2-Driven thromboxane A2 pathway suppresses Barrett's esophagus and esophageal adenocarcinoma development","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}